| Podcast

With our current climate of opioid overuse and increasing opioid related deaths, alternatives to pure mu opioids are necessary. Buprenorphine, an important weapon in the arsenal for management of substance use disorder, is now rising in popularity as an opioid option for chronic pain. Evidence has...

| Article

Newswise — Babies born after being exposed to both opioids and benzodiazepines before birth are more likely to have severe drug withdrawal, requiring medications like morphine for treatment, compared to infants exposed to opioids alone, according to a Vanderbilt University Medical Center study...

| Article

Newswise — Orthopaedic surgeons are the third-highest physician prescribers of opioids, writing more than 6 million prescriptions a year. Because over-dispensing of opioids is a factor contributing to the ongoing opioid epidemic, researchers at Johns Hopkins surveyed orthopaedic providers to better...

| Article

Newswise — In a common narrative of the path to opioid misuse, people become addicted to painkillers after a doctor prescribed them pills to treat an injury and then, later, switch to harder drugs, such as heroin. However, nonmedical opioid users were more likely to say they began abusing opioids...

| Article

Newswise — Babies exposed to opioids while their mothers were pregnant with them may need special care even before they start to experience withdrawal symptoms, according to Penn State research.

Researchers from Penn State College of Medicine found that as soon as 24 and 48 hours after birth...

| Article

With funding provided by a grant from the National Institutes for Health, a research team at the University of New Mexico Health Sciences Center is seeking to develop a vaccine that would stimulate the patient’s immune system to produce antibodies that would attack an ingested opioid. If successful...

| Video

Healthcare providers often encounter aberrant behaviors from patients who are prescribed controlled substances. Pain practitioner Jeremy Adler outlines how forming a differential diagnosis of these, drawing on a consistent plan of action, and communicating with patients can contribute to more...

| Article

An editorial appearing earlier this week in the Journal of Pain Research and coauthored by senior PAINWeek faculty member Michael Schatman, PhD, CPE, DASPE, advocates for a fresh approach to threading the needle between efforts to address the crisis of opioid abuse and the legitimate needs of...

| Article

Although medication assisted treatment offers great promise for survivors of opioid overdose, a new study led by researchers from Johns Hopkins Bloomberg School of Public Health reports that it is being substantially underapplied at the epicenter of the opioid crisis. The study of nonfatal opioid...

| Article

Looking at medication options for substance use disorder, there is buprenorphine which is a full mu opioid agonist and also has an affinity to the kappa receptor which is what makes it lower liability in terms of abuse. Buprenorphine has been around for a long time. In the 1980s it was an injectable...

Subscribe to abuse

Sign-Up